In Ovarian Cancer, Hospice Doesn't Offset Intensive End-of-Life Care
(HealthDay News) — Increasing use of hospice in the final days of ovarian cancer does not offset intensive end-of-life care in older women, according to a study published online Oct. 6 in the Journal of Clinical Oncology.
Alexi A. Wright, MD, from the Dana-Farber Cancer Institute in Boston, and colleagues examined changes in medical care during the last month of life over time for 6,956 individuals (aged ≥66 years) enrolled in fee-for-service Medicare. Patients were diagnosed with epithelial ovarian cancer between 1997 and 2007, and died as a result of ovarian cancer by December 2007.
The researchers found that between 1997 and 2007, hospice use increased significantly, and terminal hospitalizations decreased (both P<0.001). There was, however, a simultaneous, statistically significant increase in intensive care unit admissions, hospitalizations, repeated emergency department visits, and health care transitions (all P≤0.01). Over time the proportion of patients referred to hospice from inpatient settings rose (P=0.001). Compared to outpatients, inpatients referred to hospice were more likely to enroll in hospice within three days of death (adjusted odds ratio, 1.36).
"Use of hospital-based services increased over time, and patients underwent more transitions among health care settings near death, suggesting that the increasing use of hospice did not offset intensive end-of-life care," the authors write.